Transcriptomic and protein analysis of human cortex reveals genes and pathways linked to NPTX2 disruption in Alzheimer's disease
Lao, Y.; Xiao, M.-F.; Ji, S.; Piras, I. S.; Kim, K.; Bonfitto, A.; Song, S.; Aldabergenova, A.; Sloan, J.; Trejo, A.; Geula, C.; Na, C.-H.; Rogalski, E. J.; Kawas, C. H.; Corrada, M. M.; Serrano, G. E.; Beach, T. G.; Troncoso, J. C.; Huentelman, M. J.; Barnes, C. A.; Worley, P. F.; Colantuoni, C.
Show abstract
The expression of NPTX2, a neuronal immediate early gene (IEG) essential for excitatory-inhibitory balance, is altered in the earliest stages of cognitive decline that anticipate Alzheimers disease (AD). Here, we use NPTX2 as a point of reference for Omics studies to identify genes and pathways linked to its position in AD onset and progression. We integrated bulk RNA sequencing from 575 middle temporal gyrus (MTG) samples across four cohorts together with targeted proteomics in the same samples using parallel reaction monitoring-mass spectrometry in 135 representative cases, focusing on 20 curated proteins spanning synaptic, trafficking, lysosomal, and regulatory categories. NPTX2 RNA and protein were significantly reduced in AD, and to a lesser extent in mild cognitive impairment (MCI) samples. BDNF, VGF, SST, and SCG2 correlated with both NPTX2 mRNA and protein. We identified NPTX2 correlated synaptic and mitochondrial programs that were negatively correlated with lysosomal and chromatin/stress modules. Gene set enrichment analysis (GSEA) of NPTX2 correlations across all samples confirmed broad alignment with synaptic and mitochondrial compartments, while more NPTX2-specific associations were observed with proteostasis and translation regulator pathways, which were weakened in AD. In contrast, correlation of NPTX2 protein with transcriptomic profiles revealed negative associations with stress-linked transcription regulator RNAs (FOXJ1, ZHX3, SMAD5, JDP2, ZIC4), which were strengthened in AD. Studies position NPTX2 as a hub of an activity-regulated "plasticity cluster" (BDNF, VGF, SST, SCG2) that encompasses interneuron function and is embedded on a neuronal/mitochondrial integrity axis that is inversely coupled to lysosomal/chromatin-stress programs. In AD, these transcript-level correlations broadly weaken, and stress-linked transcriptional regulators become more prominent, suggesting a role in NPTX2 loss of function.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Spatially resolved transcriptomics reveals unique gene signatures associated with human temporal cortical architecture and Alzheimer's pathology 96%
- Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction, progression, and prion-like spread of Alzheimer s disease pathogenesis 95%
- Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype 95%
Similar papers in this journal
- Regional interneuron transcriptional changes reveal pathologic markers of disease progression in a mouse model of Alzheimer's disease 96%
- An interim exploratory biomarker analysis of a Phase 2 clinical trial to assess the impact of CT1812 in Alzheimers disease 96%
- Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism 94%
Similar papers in this journal
- Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina 95%
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 95%
- Molecular Signatures of Resilience to Alzheimer's Disease in Neocortical Layer 4 Neurons 95%
Similar papers in this journal
- Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies 97%
- Interrogating the plasma proteome of repetitive head impact exposure and chronic traumatic encephalopathy 97%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 96%